Larosa Joseph J Insider Trades

Insider Trading History

Track insider trading activity for Larosa Joseph J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $18.6M 29,517 shares
Last Trade
Dec 08, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$995k 1,396 shares
$712.94
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $19.4M 30,913 shares
Last Trade
Dec 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 2,476 shares
$718.36
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $7.68M 12,210 shares
Last Trade
Dec 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.87M 12,210 shares
$726.71
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $22.3M 35,525 shares
Last Trade
Nov 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.6M 14,450 shares
$737.00
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $14.4M 22,839 shares
Last Trade
Nov 20, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.35M 12,686 shares
$736.77
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $0 0 shares
Last Trade
Nov 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.6M 14,450 shares
$737.00
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $18.9M 30,075 shares
Last Trade
Dec 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$513k 702 shares
$730.81
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $19.4M 30,777 shares
Last Trade
Dec 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$387k 492 shares
$787.00
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $19.7M 31,269 shares
Last Trade
Dec 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.93M 8,981 shares
$771.64
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $23.9M 37,937 shares
Last Trade
Jul 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.03M 1,866 shares
$1,088.95
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $25M 39,803 shares
Last Trade
Jun 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.8M 11,084 shares
$1,060.13
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $9.09M 14,450 shares
Last Trade
Jun 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.4M 14,450 shares
$1,063.89
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $32M 50,887 shares
Last Trade
Jun 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.4M 14,450 shares
$1,063.89
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $0 0 shares
Last Trade
Jun 10, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.61M 1,608 shares
$1,001.73
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $21.8M 34,678 shares
Last Trade
May 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.86M 1,865 shares
$994.90
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $23M 36,543 shares
Last Trade
Feb 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$990k 1,000 shares
$990.00
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $23.6M 37,543 shares
Last Trade
Feb 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$968k 1,000 shares
$967.65
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $24.2M 38,543 shares
Last Trade
Feb 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$950k 1,000 shares
$950.00
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $40.3M 64,036 shares
Last Trade
Jan 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$31.2M 34,000 shares
$917.56
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP General Counsel And Secret
Holding Value $0 0 shares
Last Trade
Jan 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$31.2M 34,000 shares
$917.56
$628.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up